Z-0271-2023 Class II Ongoing
FDA device recall Z-0271-2023 was initiated by Kamiya Biomedical Company, LLC on Sep 28, 2022 and is designated Class II. Reason for recall: IgA Reagent may start showing cloudiness over time, which can affect assay performance. The recall status is ongoing. Affected quantity: 165.
Recall details
- Product Type
- Devices
- Report Date
- Nov 30, 2022
- Initiation Date
- Sep 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 165
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0271-2023
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Kamiya Biomedical Company, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.